Education
About Us
Working with TipRanks
Follow Us
Doseology Sciences, Inc. (TSE:MOOD)
:MOOD
RESEARCH TOOLSreports
Total Valuation
Doseology Sciences has a market cap or net worth of C$2.48M. The enterprise value is ―.
Market CapC$2.48M
Enterprise Value―
Share Statistics
Doseology Sciences has 4,500,515 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding4,500,515
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Doseology Sciences’s return on equity (ROE) is -0.33 and return on invested capital (ROIC) is -37.03%.
Return on Equity (ROE)-0.33
Return on Assets (ROA)-0.31
Return on Invested Capital (ROIC)-37.03%
Return on Capital Employed (ROCE)-0.37
Revenue Per Employee10.00T>
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.09
Inventory Turnover3.39
Valuation Ratios
The current PE Ratio of Doseology Sciences is -1.88. Doseology Sciences’s PEG ratio is -0.29.
PE Ratio-1.88
PS Ratio0.00
PB Ratio1.53
Price to Fair Value0.63
Price to FCF-7.75
Price to Operating Cash Flow-7.95
PEG Ratio-0.29
Income Statement
In the last 12 months, Doseology Sciences had revenue of 98.52K and earned -339.85K in profits. Earnings per share was -0.08.
Revenue98.52K
Gross Profit-36.08K
Operating Income-377.63K
Pretax Income-339.85K
Net Income-339.85K
EBITDA-319.48K
Earnings Per Share (EPS)-0.08
Cash Flow
In the last 12 months, operating cash flow was -174.11K and capital expenditures -4.00, giving a free cash flow of -174.11K billion.
Operating Cash Flow-174.11K
Free Cash Flow-174.11K
Free Cash Flow per Share-0.04
Dividends & Yields
Doseology Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-3.51
52-Week Price Change37.50%
50-Day Moving Average0.35
200-Day Moving Average0.24
Relative Strength Index (RSI)61.00
Average Volume (3m)12.09K
Important Dates
Doseology Sciences upcoming earnings date is Oct 30, 2025, TBA Not Confirmed.
Last Earnings DateMay 30, 2025
Next Earnings DateOct 30, 2025
Ex-Dividend Date―
Financial Position
Doseology Sciences as a current ratio of 13.36, with Debt / Equity ratio of 0.00%
Current Ratio13.36
Quick Ratio12.88
Debt to Market Cap0.00
Net Debt to EBITDA3.32
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Doseology Sciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Doseology Sciences EV to EBITDA ratio is 1.32, with an EV/FCF ratio of 1.79.
EV to Sales-4.27
EV to EBITDA1.32
EV to Free Cash Flow1.79
EV to Operating Cash Flow1.79
Balance Sheet
Doseology Sciences has C$931.17K in cash and marketable securities with C$0.00 in debt, giving a net cash position of -C$931.17K billion.
Cash & Marketable SecuritiesC$931.17K
Total DebtC$0.00
Net Cash-C$931.17K
Net Cash Per Share-C$0.21
Tangible Book Value Per ShareC$0.24
Margins
Gross margin is 3.02%, with operating margin of -383.30%, and net profit margin of -344.95%.
Gross Margin3.02%
Operating Margin-383.30%
Pretax Margin-344.95%
Net Profit Margin-344.95%
EBITDA Margin-324.27%
EBIT Margin-344.95%
Analyst Forecast
The average price target for Doseology Sciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-27.31%
EPS Growth Forecast81.88%